GlaxoSmithKline sales tick up, but China probe will hit growth

Tracy Staton GlaxoSmithKline's second-quarter results took a back seat to the goings-on in China. But sales are up just a tick. Profits dropped, falling short of analyst expectations. ...

GlaxoSmithKline CEO says HQ, British execs ‘knew nothing’ of China fraud

Tracy Staton GlaxoSmithKline CEO Andrew Witty faced a flurry of questions about China when he stood up to talk about second-quarter earnings–and he bowed out of the conference ...

China detains first U.S. citizen in pharma industry probe

Tracy Staton The Chinese pharma crackdown just keeps on widening. Now, a U.S. citizen has been detained in connection with the corruption probe, Reuters reports. And two more ...

NYT: GlaxoSmithKline’s China R&D audit found ethical breaches

Ryan McBride In the latest blow to its China operations, The New York Times has ferreted an internal audit from two years ago that found significant ethical breaches at the London-based ...

Pharma Has A “Lot Of Exposure” In China: Ted Explains

esilverman Over the past few weeks, the bribery scandal in China that is enveloping GlaxoSmithkline has caused a stir. The episode comes less than a year after the drugmaker ...

GlaxoSmithKline exec admits ‘breaches,’ promises price cuts in China

Tracy Staton Sent to deal with the developing case personally, emerging markets chief Abbas Hussain met with ministry officials–and reportedly apologized to them. Afterward, Hussain ...

GSK sends contingent to China, even as country prevents one exec from leaving

Eric Palmer Given that China is preventing a top GlaxoSmithKline exec from leaving the country as it investigates alleged bribery in the country, it seems risky to send more of his ...

As bribery probe intensifies, China confines GlaxoSmithKline finance chief to its borders

Tracy Staton In the midst of investigating GSK for bribery, Chinese officials confined GSK finance chief Steve Nechelput to the country at the end of June, Reuters reports. His boss, ...

Pharma Company Acquires Rights to Antiviral Product Line for China

barbara.lempert Marinomed Biotechnologie GmbH: Pharma Company Acquires Rights to Antiviral Product Line for China MAVIREX® technology is the basis for five products against viral ...

China crackdown: Is it designed to cut healthcare costs?

Eric Palmer Could China's very public bribery probe of GlaxoSmithKline, its review of pharmaceutical pricing and a new crackdown on quality be a master scheme to get drugmakers ...

GSK Faces Claims of Bribery in China

barbara.lempert LONDON, July 15, 2013 – China has accused the British pharmaceutical company GlaxoSmithKline (GSK) of behaving like a criminal godfather, bribing doctors with ...

China calls GSK ‘godfather’ in alleged bribery scheme

Eric Palmer Chinese law enforcement officials investigating GlaxoSmithKline for allegedly bribing docs to get business say that in the process, they have uncovered information on the ...
Page 5 of 8« First...34567...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS